ストックスクリーナーアプリを入手
0.9241
1.37%
0.0125
アフターアワーズ：
.92
-0.0041
-0.44%
前日終値:
$0.9116
開ける：
$0.94
24時間の取引高:
117.29K
Relative Volume:
0.27
時価総額：
$10.76M
収益：
$39.19M
当期純損益:
$-16.59M
株価収益率:
-0.4235
EPS:
-2.182
ネットキャッシュフロー:
$-9.39M
1週間 パフォーマンス:
+6.87%
1か月 パフォーマンス:
+3.14%
6か月 パフォーマンス:
+10.01%
1年 パフォーマンス:
-5.25%
1日の値動き範囲:
$0.9114
$0.95
1週間の範囲:
$0.8101
$0.95
52週間の値動き範囲:
$0.536
$1.19
Biofrontera Inc Stock (BFRI) Company Profile
Compare BFRI vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
0.9241 | 10.62M | 39.19M | -16.59M | -9.39M | -2.182 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.44 | 59.23B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.96 | 55.34B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.87 | 49.30B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.77 | 39.43B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
513.82 | 21.70B | 3.13B | 1.27B | 1.12B | 26.39 |
Biofrontera Inc (BFRI) 最新ニュース
U.S. Patent Office Issues Final Written Decision Finding - GlobeNewswire
Gains Recap: Will Biofrontera Inc stock go up in YEAR2025 Trading Recap & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Growth Value: Can Biofrontera Inc Equity Warrant sustain its profitabilityLong Setup & Weekly Breakout Watchlists - baoquankhu1.vn
Trading Action: Does Biofrontera Inc have high return on assets2025 Risk Factors & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Can Biofrontera Inc Equity Warrant sustain its profitabilityMarket Growth Report & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
How Biofrontera Inc. Equity Warrant stock responds to policy changesJuly 2025 Retail & Low Drawdown Momentum Ideas - mfd.ru
Fundamentals Check: Can Biofrontera Inc Equity Warrant navigate macro headwindsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Biofrontera completes key study for Ameluz skin treatment expansion By Investing.com - Investing.com South Africa
Biofrontera Emerges as Stronger Biotech Stock Compared to RenovaCare - National Today
Biofrontera completes key study for Ameluz skin treatment expansion - Investing.com
Biofrontera Inc (NASDAQ: BFRI) recently announced that the database lock for its Phase I pharmacokinetic study of Ameluz® for actinic keratosis on the trunk and extremities has been completed. - Bitget
Biofrontera Inc. Announces Database Lock of Phase 1 - GlobeNewswire
Travel Stocks: Does Biofrontera Inc have a sustainable dividend2025 Biggest Moves & High Return Trade Opportunity Guides - baoquankhu1.vn
Biofrontera reports positive phase 3 data for Ameluz in actinic keratosis - MSN
Bull Run: Is now the right time to enter Biofrontera Inc Equity Warrant - baoquankhu1.vn
Fundamentals Check: Why ETFs are accumulating Biofrontera AG (B8FK) stockJuly 2025 PostEarnings & Stepwise Trade Execution Plans - mfd.ru
Signal Recap: Is Biofrontera Inc stock a hidden gemTrade Volume Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Is Biofrontera Inc. stock near bottom after declineMarket Trend Review & AI Forecast Swing Trade Picks - mfd.ru
Biofrontera Inc. (NASDAQ:BFRI) Sees Significant Decline in Short Interest - Defense World
Will Biofrontera Inc. Equity Warrant benefit from AI trendsDollar Strength & Scalable Portfolio Growth Methods - mfd.ru
Biofrontera announces FDA filing acceptance of supplemental new drug application for Ameluz® PDT in superficial Basal Cell Carcinoma - marketscreener.com
Biofrontera Announces FDA Filing Acceptance of Supplemental - GlobeNewswire
Biofrontera's light-based option for common skin cancer under FDA review - Stock Titan
Will Biofrontera Inc. stock go up in YEAR2025 Key Highlights & Real-Time Chart Breakout Alerts - mfd.ru
Biofrontera’s Ameluz shows strong results in actinic keratosis trial By Investing.com - Investing.com Australia
Biofrontera announces positive results in phase 3 study of Ameluz® PDT - marketscreener.com
Biofrontera Reports Positive Phase 3 Ameluz PDT Results - TipRanks
Biofrontera’s Ameluz shows strong results in actinic keratosis trial - Investing.com
Light therapy gel clears more actinic keratoses on limbs, neck - Stock Titan
Biofrontera (NASDAQ:BFRI) Trading Down 5.6% – Here’s What Happened - Defense World
Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Finviz
Is Biofrontera Inc. (BFRI) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Trading Action: What are the future prospects of Biofrontera IncEarnings Beat & Verified Short-Term Trading Plans - baoquankhu1.vn
Earnings Miss: Will Biofrontera Inc stock go up in YEARJuly 2025 Rallies & Community Trade Idea Sharing Platform - baoquankhu1.vn
Aug Selloffs: Is Pitney Bowes Inc Preferred Security a turnaround story2025 Support & Resistance & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Published on: 2026-01-27 12:03:44 - baoquankhu1.vn
Aug Catalysts: Can Biofrontera Inc stock outperform in a bear marketJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Big Picture: Can Biofrontera Inc Equity Warrant sustain its profitabilityEarnings Recap Summary & Real-Time Price Movement Reports - baoquankhu1.vn
There's No Escaping Biofrontera Inc.'s (NASDAQ:BFRI) Muted Revenues Despite A 42% Share Price Rise - Sahm
Portfolio Update: Is Root Inc part of any major index2025 Fundamental Recap & Reliable Price Breakout Signals - baoquankhu1.vn
Update Recap: Is Brighthouse Financial Inc attractive at current valuationWeekly Profit Report & Capital Efficient Trade Techniques - baoquankhu1.vn
Merger Talk: Does Biofrontera Inc Equity Warrant stock reflect fundamentals2025 Bull vs Bear & Long-Term Safe Investment Ideas - baoquankhu1.vn
Can Biofrontera Inc. Equity Warrant stock maintain growth trajectoryJuly 2025 Closing Moves & Technical Buy Zone Confirmations - bollywoodhelpline.com
Aug Setups: Is Biofrontera Inc forming a breakout patternQuarterly Investment Review & AI Driven Stock Reports - baoquankhu1.vn
Gains Recap: Is Biofrontera Incs ROE strong enough2025 Market Overview & Expert Curated Trade Setups - baoquankhu1.vn
Biofrontera reports preliminary Q4 revenue $17M-$17.5M - TipRanks
Biofrontera reports record quarterly revenue in Q4 2025 By Investing.com - Investing.com Nigeria
Published on: 2026-01-14 07:20:22 - Bộ Nội Vụ
Pharma News: Can Biofrontera Inc Equity Warrant stock rebound after recent weakness2025 Trade Ideas & Fast Entry Momentum Alerts - Bộ Nội Vụ
Biofrontera reports record quarterly revenue in Q4 2025 - Investing.com
Record $17M quarter for Biofrontera as Ameluz PDT sales climb higher - Stock Titan
Biofrontera Inc (BFRI) 財務データ
収益
当期純利益
現金流量
EPS
0.00%
0.50%
大文字化:
|
ボリューム (24 時間):